Clinical gains from including both Dextroamphetamine and methylphenidate in stimulant trials

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 9, 2013, Pages 597-604

  Ramtvedt, Bjørn E ^a   Røinås, Elisabeth ^a   Aabech, Henning S ^a   Sundet, Kjetil S ^b  

^a Oslash stfold Hospital   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE; PLACEBO;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG HALF LIFE; FEMALE; HUMAN; MALE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; TASK PERFORMANCE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-OVER STUDIES; DEXTROAMPHETAMINE; DIAGNOSIS, COMPUTER-ASSISTED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PARENTS; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888088936     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0085     Document Type: Article

References (49)

1. Achenbach T, Rescorla L: Manual for the ASEBA School-Age Forms & Profiles: Child Behavior Checklist for Ages 6-18, Teachers Report Form, Youth Self-Report: An Integrated System of Multi- Informant Assessment. Burlington, VT: University of Vermont, Research Center for Children, Youth & Families, 2001
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000
3. Arnold L: Methylphenidate vs. amphetamine: Comparative review. J Atten Disord 3:200-211, 2000
4. Arnold LE, Christopher J, Huestis R, Smeltzer DJ: Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: Controlled comparison by placebo washout design with Bayes analysis. Arch Gen Psychiatry 35:463-473, 1978 (Pubitemid 8337038)
5. Bergfalk H: Qb Test User Manual. Gothenburg, Sweden: Qbtech AB; 2003
6. Biederman J, Monuteaux MC, Spencer T, Wilens TE, Faraone SV: Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics 124:71-78, 2009
7. Borcherding BG, Keysor CS, Cooper TB, Rapoport JL: Differential effects of methylphenidate and dextroamphetamine on motor activity level of hyperactive children. Neuropsychopharmacology 2:255-263, 1989 (Pubitemid 20025252)
8. Brager-Larsen LM: WASI (Wechsler abbreviated scale of intelligence): Norwegian edition. Oslo: L.M. Brager-Larsen, 2001
9. Brocki KC, Tillman CM, Bohlin G: CPT performance, motor activity, and continuous relations to ADHD symptom domains: A developmental study. Eur J Dev Psychol 7:178-197, 2010
10. Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder: Treatment of attention-deficit/hyperactivity disorder: Overview of the evidence. Pediatrics 115:e749-757, 2005
11. Charach A, Ickowicz A, Schachar R: Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry 43:559-567, 2004 (Pubitemid 38812367)
12. Cohen JW: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: J. Willey; 1988
13. Conners K: Conners Rating Scales-Revised: Technical Manual. North Tonawanda, NY: Multi-Health Systems; 1997
14. Efron D, Jarman F, Barker M: Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Pediatrics 100:E6, 1997
15. Elia J, Borcherding BG, Rapoport JL, Keysor CS: Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders? Psychiatry Res 36:141-155, 1991
16. Elia J, Welsh PA, Gullotta CS, Rapoport JL: Classroom academic performance: Improvement with bothmethylphenidate and dextroamphetamine in ADHD boys. J Child Psychol Psychiatry 34:785-804, 1993 (Pubitemid 23204730)
17. Evans SW, Pelham WE, Smith BH, Bukstein O, Gnagy EM, Greiner AR, Altenderfer L, Baron-Myak C: Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol 9:163-175, 2001 (Pubitemid 32852317)
18. Faraone SV, Biederman J, Zimmerman B: Correspondence of parent and teacher reports in medication trials. Eur Child Adolesc Psychiatry 14:20-27, 2005
19. Faraone SV, Buitelaar J: Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. Eur Child Adolesc Psychiatry 19:353-364, 2010
20. Faraone SV, Sergeant J, Gillberg C, Biederman J: The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2:104-113, 2003
21. Fernandez-Jaen A, Fernandez-Mayoralas DM, Pardos A, Calleja- Perez B, Munoz Jareno N: Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/ hyperactivity disorder: efficacy evaluation. Adv Ther 26:1097-1110, 2009
22. Gioia, G.A., Isquith, P.K.: BRIEF Behavior Rating Inventory of Executive Function: Professional Manual. Odessa, FL: PAR Psychological Assessment Resources; 2000
23. Gomez R, Burns GL, Walsh JA, de Moura MA: A multitrait- multisource confirmatory factor analytic approach to the construct validity of ADHD rating scales. Psychol Assess 15:3-16, 2003 (Pubitemid 36314922)
24. Green C: Methylphenidate vs dexamphetamine: A clinical audit. J Paediatr Child Health 32:470-470, 1996
25. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S: American Academy of Child and Adolescent Psychiatry: Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41:26S-49S, 2002
26. Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, Arnold LE, Abikoff HB, Bukstein OG, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Wells K, Wigal T. Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. J AM Acad Child Adolesc Psychiatry 40:180-187, 2001 (Pubitemid 32111021)
27. Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliot G, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells K: Medication treatment strategies in the MTA study: Relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 34:1304-1313, 1996 (Pubitemid 26327704)
28. Halmoy A, Fasmer OB, Gillberg C, Haavik J: Occupational outcome in adult ADHD: Impact of symptom profile, comorbid psychiatric problems, and treatment: A cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord 13:175-187, 2009
29. Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B: ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40:147-158, 2001a. (Pubitemid 32111018)
30. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff HB, Elliott G, Hechtman L, Hoza B, March JS, Newcorn JH, Severe JB, Vitiello B, Wells K,Wigal T: Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. J Dev Behav Pediatr 22:60-73, 2001b. (Pubitemid 33040478)
31. Knagelhjelm P, Ulberstad F: Qb Test: Technical Manual. Stockholm: Qbtech AB; 2010
32. Lis S, Baer N, Stein-en-Nosse C, Gallhofer B, Sammer G, Kirsch P: Objective measurement of motor activity during cognitive performance in adults with attention-deficit/hyperactivity disorder. Acta Psychiatr Scand 122:285-294, 2010
33. Pelham W, Greenslade K, Vodde-Hamilton M, Murphy D, Greenstein J, Gnagy E, Guthrie K, Hoover M, Dahl R: Relative efficacy of long-acting stimulants on children with Attention Deficit- Hyperactivity Disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and premoline. Pediatrics 86:226-237, 1990 (Pubitemid 20238855)
34. Polanczyk G, Jensen P: Epidemiologic considerations in attention deficit hyperactivity disorder: A review and update. Child Adolesc Psychiatr Clin N Am 17:245-260, vii, 2008 (Pubitemid 351265397)
35. Porrino LJ, Rapoport JL, Behar D, Sceery W, Ismond DR, Bunney WE, Jr: A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry 40:681-687, 1983 (Pubitemid 13094937)
36. Powers RL, Marks DJ, Miller CJ, Newcorn JH, Halperin JM: Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. J Child Adolesc Psychopharmacol 18:449-459, 2008
37. Rapport M, Jones J, DuPaul G, Kelly KL, Gardner M, Tucker SB, Shea M: Attention deficit disorder and methylphenidate: Group and single-subject analyses of dose effects on attention in clinic and classroom settings. J Clinic Child Psychol 16:329-338, 1987
38. Rapport MD, Denney C: Titrating methylphenidate in children with attention-deficit/hyperactivity disorder: Is body mass predictive of clinical response? J Am Acad Child Adolesc Psychiatry 36:523-530, 1997 (Pubitemid 27149190)
39. Safer DJ, Zito JM, Fine EM: Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98:1084-1088, 1996 (Pubitemid 26399270)
40. Skirbekk B, Hansen BH, Oerbeck B, Kristensen H: The relationship between sluggish cognitive tempo, subtypes of attention-deficit/ hyperactivity disorder, and anxiety disorders. J Abnorm Child Psychol 39:513-525, 2011
41. Sumner CR, Haynes VS, Teicher MH, Newcorn JH: Does placebo response differ between objective and subjective measures in children with attention-deficit/hyperactivity disorder? Postgrad Med 122:52-61, 2010
42. Swanson J, Gupta S, Williams L, Agler D, Lerner M, Wigal S: Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: Effects on activity level in the classroom and on the playground. J Am Acad Child Adolesc Psychiatry 41:1306-1314, 2002 (Pubitemid 38338021)
43. Swanson J, Lerner M, March J, Gresham FM: Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study. Pediatr Clin North Am 46:993-1009, 1999 (Pubitemid 29477886)
44. Tabori-Kraft J, Sorensen MJ, Kaergaard M, Dalsgaard S, Thomsen PH: Is OPTAx useful for monitoring the effect of stimulants on hyperactivity and inattention? A brief report. Eur Child Adolesc Psychiatry 16:347-351, 2007 (Pubitemid 47305454)
45. Teicher MH, Polcari A, McGreenery CE: Utility of objective measures of activity and attention in the assessment of therapeutic response to stimulants in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 18:265-270, 2008
46. Vogt C, Willimas T: Early identification of stimulant treatment responders, partial responders and non-responders using objective measures in children and adolescents with Hyperkinetic Disorder. Child Adolesc Ment Health 16:144-149, 2011
47. Waschbusch DA, Pelham WE, Jr, Waxmonsky J, Johnston C: Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder? J Dev Behav Pediatr 30:158-168, 2009
48. Wechsler D: WISC-III: Manual (Swedish edition), 3rd ed. Stockholm: Pykologiförlaget; 1999
49. Zoega H, Furu K, Halldorsson M, Thomsen PH, Sourander A, Martikainen JE: Use of ADHD drugs in the Nordic countries: a population- based comparison study. Acta Psychiatr Scand 123:360-367, 2011.